Study on mechanism of action of Chinese medicine Chan Su: dose-dependent biphasic production of nitric oxide in trophoblastic BeWo cells

Hong, 1992, Simultaneous determination of bufadienolides in traditional Chinese medicine preparations Liu-Shen-Wan by liquid chromatography, J. Pharm. Pharmacol., 44, 1023, 10.1111/j.2042-7158.1992.tb07086.x

Chan, 1995, Examination of toxicity of a Chinese drug, the toad glandular secretion product Chan Su in pregnant mice and embryos, Biol. Neonate, 67, 376, 10.1159/000244188

Chen, 1967, Pharmacology and toxicology of toad venom, J. Pharm. Sci., 56, 1535, 10.1002/jps.2600561202

Morishita, 1992, Pharmacological actions of “Kyushin” a drug containing toad venom: cardiotonic and arrhythmogenic effects and excitatory effect on respiration, Am. J. Chin. Med., 20, 245, 10.1142/S0192415X92000254

Pamnani, 1991, Effect of three sodium-potassium adenosine triphosphate inhibitors, Hypertension, 18, 316, 10.1161/01.HYP.18.3.316

Ko, 1996, Lethal ingestion of Chinese tea containing Chan Su, West. J. Med., 164, 71

Eisenberg, 1993, Unconventional medicine in the United States; prevalence, cost, and patterns of use, N. Engl. J. Med., 328, 246, 10.1056/NEJM199301283280406

Hobbs, 1999, Inhibition of nitric oxide synthase as a potential therapeutic target, Annu. Rev. Pharmacol. Toxicol., 39, 191, 10.1146/annurev.pharmtox.39.1.191

Murad, 1998, Would you believe that a simple free radical could be a second messenger, autacoid, paracrine substance, neurotransmitter and hormone?, Recent Prog. Horm. Res., 53, 43

Kiss, 1998, Expression of endothelial (type III) nitric oxide synthase in cytotrphoblastic cell line: regulation by hypoxia and inflammatory cytokines, Placenta, 19, 603, 10.1016/S0143-4004(98)90021-2

Datta, 2002, Effect of Chinese medicines Chan Su and Danshen on EMIT 2000 and Randox digoxin immunoassays: wide variation in digoxin-like immunoreactivity and magnitude of interference in digoxin measurement by different brands of the same product, Ther. Drug Monit., 24, 637, 10.1097/00007691-200210000-00010

Dasgupta, 2000, Positive and negative interference of the Chinese medicine Chan Su in serum digoxin measurement: elimination of interference by using a monoclonal chemiluminescent digoxin assay or monitoring free digoxin concentration, Am. J. Clin. Pathol., 114, 174, 10.1309/BTFH-L0UH-P326-UB5D

Panesar, 1992, Bufalin and unidentified substances in traditional Chinese medicines cross react in commercial digoxin assay, Clin. Chem., 38, 246, 10.1093/clinchem/38.10.2155

Fushimi, 1995, Digoxin concentration in blood, Rinsho Byori, 43, 34

Brubacher, 1996, Treatment of toad venom poisoning with digoxin-specific fab fragments, Chest, 110, 1282, 10.1378/chest.110.5.1282

Dasgupta, 1998, Rapid detection of cardioactive bufalin toxicity using fluorescence polarization immunoassay for digitoxin, Ther. Drug Monit., 20, 104, 10.1097/00007691-199802000-00019

Bagrov, 1993, Digitalis-like and vasoconstrictor effects of endogenous digoxin-like factors from the venom of Bufo marinus toad, Eur. J. Pharmacol., 234, 165, 10.1016/0014-2999(93)90950-M

Bick, 2002, Effects of Chan Su, a traditional Chinese medicine, on the calcium transients of isolated cardiomyocytes; cardiotoxicity due to more than Na,K-ATPase blocking, Life Sci., 72, 699, 10.1016/S0024-3205(02)02302-0